Drug Enforcement D-0121-2025

Superpotent Drug and Subpotent Drug: potency failures obtained

Status

Ongoing

Classification

Class II

Report Date

December 18, 2024

Termination Date

—

Product Information

Product description
Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Product quantity
19, 549 bottles
Reason for recall
Superpotent Drug and Subpotent Drug: potency failures obtained
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide within the United States and Puerto Rico

Location & Firm

Recalling firm
Viatris Inc
Address
1000 Mylan Blvd

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0121-2025
Event ID
95768
Recall initiation date
November 18, 2024
Center classification date
December 12, 2024
Code info
Lot #: a) 3192915, 8172108, Exp. Date Mar 2025; b) 3208680, Exp. Date Sep 2025
More code info
—